Best Agrolife (539660) Q1 26/27 earnings summary

Executive summary

• Q1 FY27 saw resilient performance with revenue up 4% year-on-year to ₹396 crore and profit after tax doubling to ₹41 crore, driven by margin expansion, operational efficiencies, and a shift to patented products.

• Key patented products, including new launches Fluzam and Cubax Power Extra, gained market acceptance and contributed to growth despite delayed monsoon and subdued demand.

• Focus remained on innovation, operational efficiency, and expanding market presence to drive sustainable value.

• Working capital efficiency improved, with inventory reduced by 6% year-on-year.

Financial highlights

• Revenue from operations grew 4% year-on-year to ₹396 crore; gross profit rose 32% to ₹146 crore, with gross margin improving to 37% from 29%.

• EBITDA increased 70% year-on-year to ₹78 crore, with EBITDA margin at 20% (up from 12%).

• Profit after tax more than doubled to ₹41 crore; PAT margin improved to 10% from 5%.

• Operating expenses rose only 4%-4.5% year-on-year despite continued investment in market development.

• Inventory reduced to ₹764 crore from ₹812 crore year-on-year, reflecting improved working capital.

Outlook and guidance

• Management expects Q2 to be strong as delayed demand shifts from Q1, with continued focus on profitability, innovation, and working capital efficiency.

• Patent portfolio contribution to branded sales expected to remain between 60%-70% for the year.

• Revenue CAGR targeted at 10%-15% over the next 3-4 years, with sustainable EBITDA margins of 13%-14%.

• No new product launches planned for the remainder of the year; pipeline products depend on regulatory approvals.